Dr Danijela Kocic
PhD, BSc (Hons)
Dr Danijela Kocic is the Scientific Head of Clinical Pharmacology and Toxicology for SydPath at the St. Vincent’s Hospital in Sydney, Australia. She manages the analysis of Therapeutic Drug Monitoring results to clinicians, patients and other clients requesting rigorous analytical services with a view to optimising patient outcomes in a variety of complex clinical settingsDr Kocic is an active member of TDM Matters Multi-Disciplinary Team Service at St Vincent’s Hospital and recently was appointed as a Conjoint Lecturer at St Vincent’s Clinical School, University of NSW. Dr Kocic is a leading committee member of the NSW Health Pathology Clinical Mass Spectrometry Forum.
Dr Kocic commenced her scientific career with Novartis Pharmaceuticals as a Research Scientist. Following the completion of her PhD, she moved to the Drug Toxicology Unit of the NSW Forensic and Analytical Scientific Service as a Senior Scientist in Charge of Research & Development and Innovation, continuing to develop high-throughput, robust methods for drug detection and confirmation.
Her research interests are the improvement of the sample throughput of standard LC-MS/MS equipment using Active Flow Technology, TDM and personalised medicine.
- Publications
- Media
- Grants
- Awards
- Research Activities
- Engagement
- Teaching and Supervision
Dean’s Merit List 2008
University of Western Sydney
For Academic Excellence
Dean’s Medal 2009
University of Western Sydney
For Academic Excellence
Employee of the Year 2009
Novartis AH
For GLP Method Development and Validation
Dean’s Merit List 2009
University of Western Sydney
For Academic Excellence
Ellice Swinbourne Prize 2009
University of Western Sydney
For the outstanding performance in Chemistry
Honours Scholarship 2009
The University of Western Sydney
Dean’s Merit List 2010
University of Western Sydney
For Academic Excellence
Australian Postgraduate Award 2012
Department of Industry, Innovation Science, Research and Tertiary
Education
Quarterly Innovation Award 2012
Novartis AH
For Non-GLP Method Development and Validation
UWS Innovators Award 2014
University of Western Sydney, For demonstrated Innovation Excellence
Emerging Leaders Program 2017
NSW Health Pathology, for demonstrated Leadership Skills, 9 months program
Method development and validation for TDM using LC-MS/MS.
Using of novel chromatography columns to achieve ultra-high performance assays.
Lead committee member for NSW Health Pathology Clinical Mass Spectrometry Forum
My Research Supervision
ILP Student - Therapeutic Drug Monitoring of Tuberculosis Drugs